A randomized controlled trial on the application of a chronic disease management platform based on digital health technology combined with an innovative model of intelligent management for hypertension in patients with hypertension
Keli Liu, Benshan Niu, Xiaoyi Zhang, Lingyuan Zhang, Yuexia Gao, Juying Lu · 2026
Read A randomized controlled trial on the application of a chronic disease management platform based on digital health technology combined with an innovative model of intelligent management for hypertension in patients with hypertension by Keli Liu, Benshan Niu, Xiaoyi Zhang, Lingyuan Zhang, Yuexia Gao, Juying Lu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12883777.txt.
Description
Keli Liu and co-authors test a digital platform for long-term control of high blood pressure, in a trial first shared in 2025, though the catalog lists 2026. The platform pairs a phone-based system with a smart care model that teaches patients and checks on them over time. The trial ran at a university hospital in Nantong, China. It compared the platform with standard face-to-face care.
The trial signed up 570 adults whose blood pressure was not yet under control. Half used the platform and half got routine care, and 547 finished the study. After twelve months, the platform group cut their top pressure reading more than the control group. The gain was largest for patients who began with lower readings. Even a small drop in pressure can cut heart risk by a fair share. The results favor digital tools for daily pressure care.
Catalog record
| CREATOR | Keli Liu, Benshan Niu, Xiaoyi Zhang, Lingyuan Zhang, Yuexia Gao, Juying Lu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 40 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |